Quantification of immune cells (CD20+ B cells, CD4+ T cells, CD8+T cells, CD68+ Macrophages, and CD163+ TAMs) in our 304 glioma cases (WHO I–IV). The gene discussed is CD8A; the disease is central nervous system cancer.